ARPANSA activities in response to COVID-19
Updated 24 March 2020
As a Federal Government Agency working under the Department of Health, ARPANSA is committed to supporting the health and safety of all Australians. During this period, as the Government works to protect the community from the effects of the novel coronavirus (COVID-19), we are working to support our staff and all stakeholders as we do our part to reduce the spread.
For up-to-date information and advice on COVID-19, please refer to the Department of Health website.
Our offices in Sydney (Miranda) and Melbourne (Yallambie) are now closed, with the exception that a small number of staff will continue to attend the Yallambie offices to maintain essential services.
The majority of our staff will be working remotely during this time. We are well-equipped to support activities through remote work. However, there will be suspension or adjustment of some activities as follows:
- Regulatory activities will continue with the exception that the majority of on-site inspections have now been postponed.
- Our Talk to a Scientist program will continue to be available via email and our website contact form. However, over the phone support will be unavailable until further notice.
- Customers of our Personal Radiation Monitoring Service (PRMS) will be contacted directly with advice regarding any specific changes to services. However, this service is planned to continue. We anticipate that there will be some delays.
- Our Ultraviolet Radiation, Radioanalytical and Radiofrequency laboratories have been temporarily closed and are not currently accepting new work orders.
- Our Australian Clinical Dosimetry Service (ACDS) has been temporarily suspended and staff will continue to work closely with hospitals to assess any urgent need for audit of radiotherapy machines.
- Hire of radiation meters has been suspended until further notice.
All other activities, including our Comprehensive Test Ban Treaty radionuclide monitoring system, medical permits, UV monitoring network and other radiation monitoring programs are planned to continue to operate as normal.
We will provide further updates to this advice as required.